Catalyst Wire Dossier Catalyst Wire Dossier

Aitua

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aitua, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer [Phase 2]

See pricing